LGALS9 and COVID-19: We need a larger-scale study to find the precise outcomes of plasma N-cleaved-Gal9 in COVID-19 and accurately assess the availability of plasma N-cleaved-Gal9 as a marker for determining COVID-19 severity and therapeutic effects of TCZ.